|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4351337A
(en)
|
1973-05-17 |
1982-09-28 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery device, and process for preparing and using the same
|
|
US3941763A
(en)
|
1975-03-28 |
1976-03-02 |
American Home Products Corporation |
PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
US4083368A
(en)
|
1976-09-01 |
1978-04-11 |
Freezer Winthrop J |
Inhaler
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
US5002936A
(en)
|
1985-04-12 |
1991-03-26 |
Seymour Lieberman |
Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
JP2876058B2
(ja)
|
1986-08-18 |
1999-03-31 |
エミスフィア・テクノロジーズ・インコーポレイテッド |
薬物送達システム
|
|
WO1988001649A1
(en)
|
1986-09-02 |
1988-03-10 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
AU607172B2
(en)
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
|
US4906169A
(en)
|
1986-12-29 |
1990-03-06 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
|
US5023084A
(en)
|
1986-12-29 |
1991-06-11 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
|
US4983395A
(en)
|
1987-11-12 |
1991-01-08 |
Theratech Inc. |
Device for administering an active agent to the skin or mucosa
|
|
US4849224A
(en)
|
1987-11-12 |
1989-07-18 |
Theratech Inc. |
Device for administering an active agent to the skin or mucosa
|
|
US4847325A
(en)
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
|
JP3092811B2
(ja)
|
1988-07-23 |
2000-09-25 |
デルタ バイオテクノロジー リミテッド |
ペプチドおよびｄｎａ配列
|
|
US4925677A
(en)
|
1988-08-31 |
1990-05-15 |
Theratech, Inc. |
Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5171264A
(en)
|
1990-02-28 |
1992-12-15 |
Massachusetts Institute Of Technology |
Immobilized polyethylene oxide star molecules for bioapplications
|
|
US6552170B1
(en)
|
1990-04-06 |
2003-04-22 |
Amgen Inc. |
PEGylation reagents and compounds formed therewith
|
|
JP3051145B2
(ja)
|
1990-08-28 |
2000-06-12 |
住友製薬株式会社 |
新規なポリエチレングリコール誘導体修飾ペプチド
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
AU643141B2
(en)
|
1991-03-15 |
1993-11-04 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
ATE240740T1
(de)
|
1991-03-15 |
2003-06-15 |
Amgen Inc |
Pegylation von polypeptiden
|
|
EP0617706B1
(en)
|
1991-11-25 |
2001-10-17 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
|
JPH0640945A
(ja)
|
1992-07-23 |
1994-02-15 |
Kureha Chem Ind Co Ltd |
Ｆｃフラグメント結合抗腫瘍剤
|
|
AU5171293A
(en)
|
1992-10-14 |
1994-05-09 |
Regents Of The University Of Colorado, The |
Ion-pairing of drugs for improved efficacy and delivery
|
|
US5346701A
(en)
|
1993-02-22 |
1994-09-13 |
Theratech, Inc. |
Transmucosal delivery of macromolecular drugs
|
|
US5432155A
(en)
|
1993-06-29 |
1995-07-11 |
The Salk Institute For Biological Studies |
Conotoxins I
|
|
US5514774A
(en)
|
1993-06-29 |
1996-05-07 |
University Of Utah Research Foundation |
Conotoxin peptides
|
|
US5460820B1
(en)
|
1993-08-03 |
1999-08-03 |
Theratech Inc |
Method for providing testosterone and optionally estrogen replacement therapy to women
|
|
US6342225B1
(en)
|
1993-08-13 |
2002-01-29 |
Deutshces Wollforschungsinstitut |
Pharmaceutical active conjugates
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
MX9603570A
(es)
|
1994-02-23 |
1997-03-29 |
Chiron Corp |
Metodo y composiciones para incrementar la vida media en suero de agentes farmacologicamente activos.
|
|
FR2717688B1
(fr)
|
1994-03-28 |
1996-07-05 |
Lhd Lab Hygiene Dietetique |
Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
EP0799029A1
(en)
|
1994-12-21 |
1997-10-08 |
Theratech, Inc. |
Transdermal delivery system with adhesive overlay and peel seal disc
|
|
ATE236617T1
(de)
|
1994-12-22 |
2003-04-15 |
Astrazeneca Ab |
Aerosol-arzneiformulierungen
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
US5776896A
(en)
|
1996-01-03 |
1998-07-07 |
Zeneca Limited |
Analgesic peptides from venom of grammostola spatulata and use thereof
|
|
US5756663A
(en)
|
1996-01-03 |
1998-05-26 |
Zeneca Limited |
Antiarrhythmic peptide from venom of spider Grammostola spatulata
|
|
JP4046354B2
(ja)
|
1996-03-18 |
2008-02-13 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
増大した半減期を有する免疫グロブリン様ドメイン
|
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
US6077680A
(en)
|
1996-11-27 |
2000-06-20 |
The University Of Florida |
ShK toxin compositions and methods of use
|
|
US6689749B1
(en)
|
1996-12-19 |
2004-02-10 |
Suntory Limited |
Neuropeptides originating in scorpion
|
|
US6548644B1
(en)
|
1997-03-10 |
2003-04-15 |
Immunex Corporation |
Site protected protein modification
|
|
US5990237A
(en)
|
1997-05-21 |
1999-11-23 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
|
|
JP3530004B2
(ja)
|
1998-02-06 |
2004-05-24 |
株式会社日立ユニシアオートモティブ |
吸入式投薬器
|
|
US6022952A
(en)
|
1998-04-01 |
2000-02-08 |
University Of Alberta |
Compositions and methods for protein secretion
|
|
US6451986B1
(en)
|
1998-06-22 |
2002-09-17 |
Immunex Corporation |
Site specific protein modification
|
|
AUPP589598A0
(en)
|
1998-09-14 |
1998-10-08 |
University Of Queensland, The |
Novel peptides
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
CA2350226C
(en)
|
1998-11-20 |
2012-04-24 |
Fuso Pharmaceutical Industries, Ltd. |
Protein expression vector and utilization thereof
|
|
JP2002533378A
(ja)
|
1998-12-23 |
2002-10-08 |
アムジエン・インコーポレーテツド |
タンパク質の徐放用ポリオール／油懸濁液
|
|
US6245740B1
(en)
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
|
EP1181390A4
(en)
|
1999-03-18 |
2004-08-04 |
Human Genome Sciences Inc |
27 HUMAN SECRETED PROTEINS
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
WO2001038564A2
(en)
|
1999-11-26 |
2001-05-31 |
Mcgill University |
Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
|
|
CA2393616A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
AU2001238595A1
(en)
|
2000-02-22 |
2001-09-03 |
Shearwater Corporation |
N-maleimidyl polymer derivatives
|
|
SE0000935D0
(sv)
|
2000-03-21 |
2000-03-21 |
Astrazeneca Ab |
An inhalation device
|
|
US7125847B1
(en)
|
2000-04-07 |
2006-10-24 |
The Research Foundation Of State University Of New York At Buffalo |
Mechanically activated channel blocker
|
|
CN1133461C
(zh)
|
2000-04-11 |
2004-01-07 |
厦门北大之路生物工程有限公司 |
虎纹捕鸟蜘蛛毒素提取物在制备镇痛药物中的应用
|
|
WO2001079444A2
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc |
Albumin fusion proteins
|
|
ATE301190T1
(de)
|
2000-05-10 |
2005-08-15 |
Centre Nat Rech Scient |
Protonen-abhängiges na+kanal hemmendes polypeptid
|
|
EP1177806A1
(en)
|
2000-08-04 |
2002-02-06 |
The Technology Partnership Public Limited Company |
Dry powder inhaler
|
|
GB0021617D0
(en)
|
2000-09-02 |
2000-10-18 |
Imp College Innovations Ltd |
Diagnosis and treatment of cancer
|
|
JP5013152B2
(ja)
|
2001-02-28 |
2012-08-29 |
株式会社ビーエムジー |
蛋白質複合体形成剤
|
|
EP1377306A1
(en)
|
2001-03-09 |
2004-01-07 |
Dyax Corp. |
Serum albumin binding moieties
|
|
US20050054051A1
(en)
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP2341148A3
(en)
|
2001-04-12 |
2012-05-30 |
Imperial Innovations Limited |
Diagnosis and treatment of cancer
|
|
GB0120238D0
(en)
|
2001-08-20 |
2001-10-10 |
Univ College Of London |
Sodium channel regulators and modulators
|
|
CN101785861B
(zh)
|
2001-10-19 |
2014-08-13 |
爱德士实验室公司 |
用于药理活性化合物的可控释放的可注射组合物
|
|
US6900317B2
(en)
|
2002-02-19 |
2005-05-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
|
|
WO2003072751A2
(en)
|
2002-02-25 |
2003-09-04 |
Vanderbilt University |
Expression system for human brain-specific voltage-gated sodium channel, type 1
|
|
US20030191056A1
(en)
|
2002-04-04 |
2003-10-09 |
Kenneth Walker |
Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
|
|
JP4638225B2
(ja)
|
2002-05-30 |
2011-02-23 |
ザ スクリプス リサーチ インスティテュート |
銅を触媒とするアジドとアセチレンのライゲーション
|
|
GB0219512D0
(en)
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Inhalation compositions with high drug ratios
|
|
EP1609861B1
(en)
|
2003-03-26 |
2009-10-28 |
Pharmadesign, INC. |
Low-molecular weight peptides inhibiting ion channel activity
|
|
MXPA05013564A
(es)
|
2003-06-12 |
2006-03-09 |
Lilly Co Eli |
Proteinas de fusion.
|
|
TW200521119A
(en)
|
2003-08-05 |
2005-07-01 |
Vertex Pharma |
Compositions useful as inhibitors of voltage-gated ion channels
|
|
US7615563B2
(en)
|
2003-08-08 |
2009-11-10 |
Gonzalez Iii Jesus E |
Compositions useful as inhibitors of voltage-gated sodium channels
|
|
KR20060073930A
(ko)
|
2003-08-08 |
2006-06-29 |
버텍스 파마슈티칼스 인코포레이티드 |
통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
|
|
US7060723B2
(en)
|
2003-08-29 |
2006-06-13 |
Allergan, Inc. |
Treating neurological disorders using selective antagonists of persistent sodium current
|
|
US7125908B2
(en)
|
2003-08-29 |
2006-10-24 |
Allergan, Inc. |
Treating pain using selective antagonists of persistent sodium current
|
|
CA2553745A1
(en)
|
2004-01-21 |
2005-08-04 |
University Of Utah Research Foundation |
Mutant sodium channel nav1.7 and methods related thereto
|
|
WO2005118614A1
(en)
|
2004-04-08 |
2005-12-15 |
Avigen, Inc. |
Methods and compositions for treating neuropathic pain
|
|
EP1750683B1
(en)
|
2004-04-23 |
2013-01-09 |
Amgen Inc. |
Sustained release formulations
|
|
EP1759437A1
(de)
|
2004-06-23 |
2007-03-07 |
Huber+Suhner Ag |
Breitband-patchantenne
|
|
GB0414272D0
(en)
|
2004-06-25 |
2004-07-28 |
Cellpep Sa |
OsK1 derivatives
|
|
WO2006014493A2
(en)
|
2004-07-07 |
2006-02-09 |
The Research Foundation Of State University Of New York Stor |
Mechanically activated channel blocker
|
|
BRPI0516011A
(pt)
|
2004-09-24 |
2008-08-19 |
Amgen Inc |
moléculas fc modificadas
|
|
EP2474316B1
(en)
|
2004-10-07 |
2016-04-06 |
The Regents of The University of California |
Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels
|
|
US7767680B2
(en)
|
2004-11-03 |
2010-08-03 |
Vertex Pharmaceuticals Incorporated |
Ion channel modulators and methods of use
|
|
US20060199812A1
(en)
|
2005-01-24 |
2006-09-07 |
Amgen Inc. |
Method of conjugating aminothiol containing molecules to vehicles
|
|
WO2006101629A2
(en)
|
2005-02-17 |
2006-09-28 |
Vertex Pharmaceuticals Incorporated |
SODIUM CHANNEL PROTEIN TYPE III α-SUBUNIT SPLICE VARIANT
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
GB0517487D0
(en)
|
2005-08-26 |
2005-10-05 |
Isis Innovation |
Antibodies
|
|
US7972813B2
(en)
|
2005-09-30 |
2011-07-05 |
Vertex Pharmaceuticals Incorporated |
Tetrodotoxin-resistant sodium channel alpha subunit
|
|
EP1948685B1
(en)
|
2005-11-08 |
2018-04-18 |
Activen Sa |
Mu-conotoxin peptides and use thereof as a local anesthetic
|
|
WO2007109324A2
(en)
|
2006-03-21 |
2007-09-27 |
Xenon Pharmaceuticals, Inc. |
Potent and selective nav 1.7 sodium channel blockers
|
|
WO2007149542A2
(en)
|
2006-06-20 |
2007-12-27 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Antimicrobial kinocidin compositions and methods of use
|
|
JP4742345B2
(ja)
*
|
2006-06-20 |
2011-08-10 |
独立行政法人産業技術総合研究所 |
カルシウムチャネルを遮断するグラモストラ・スパチュラタ由来のポリペプチドおよびその遺伝子
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
US8183221B2
(en)
|
2007-09-05 |
2012-05-22 |
Medtronic, Inc. |
Suppression of SCN9A gene expression and/or function for the treatment of pain
|
|
CN101480393A
(zh)
*
|
2008-01-07 |
2009-07-15 |
云南昊邦制药有限公司 |
草乌甲素作为制备治疗Nav1.7疼痛病症药物的应用
|
|
EP2249856B1
(en)
|
2008-01-30 |
2013-11-06 |
Baylor College Of Medicine |
Peptides that target dorsal root ganglion neurons
|
|
US20110312533A1
(en)
|
2009-02-02 |
2011-12-22 |
Chromocell Corporation |
CELL LINES EXPRESSING NaV AND METHODS OF USING THEM
|
|
JP5717143B2
(ja)
*
|
2009-03-10 |
2015-05-13 |
独立行政法人産業技術総合研究所 |
ポリペプチドライブラリーを調製する方法
|
|
WO2010104115A1
(ja)
*
|
2009-03-10 |
2010-09-16 |
独立行政法人産業技術総合研究所 |
膜タンパク質を特異的に認識するポリペプチドの調製方法
|
|
EP2432488A4
(en)
|
2009-03-20 |
2014-01-08 |
Amgen Inc |
SELECTIVE AND POWERFUL KV1.3 PEPTIDE INHIBITORS
|
|
BR112012005860A2
(pt)
|
2009-09-15 |
2017-01-31 |
Alomone Preclinical Ltd |
peptídeos isolados do veneno de aranha, e usos dos mesmos
|
|
GB0922435D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
Method
|
|
GB0922434D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
antibodies and fragments thereof
|
|
US8734798B2
(en)
|
2009-10-27 |
2014-05-27 |
Ucb Pharma S.A. |
Function modifying NAv 1.7 antibodies
|
|
US8871996B2
(en)
|
2010-06-09 |
2014-10-28 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing human voltage-gated sodium channels
|
|
US9279003B2
(en)
|
2010-07-07 |
2016-03-08 |
Purdue Pharma L.P. |
Analogs of sodium channel peptide toxin
|
|
AU2013262630B2
(en)
|
2012-05-18 |
2017-11-16 |
Janssen Biotech, Inc. |
Huwentoxin-IV variants and methods of use
|